Quest Diagnostics Inc (DGX)

$170.85 +3.44 (2.05%)
Market Cap 19.10B
Revenue (ttm) 9.87B
Net Income (ttm) 871.00M
EPS (ttm) N/A
PE Ratio 17.89
Forward PE 17.20
Profit Margin 8.82%
Debt to Equity Ratio 0.78
Volume 1,421,000
Avg Vol 1,110,198
Day's Range N/A - N/A
Shares Out 111.82M
Stochastic %K 34%
Beta 0.46
Analysts Strong Sell
Price Target $188.71

Company Profile

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 973 520 2700
Address:
500 Plaza Drive, Secaucus, United States
andftbl
andftbl Aug. 1 at 4:28 PM
$DGX Back up?
0 · Reply
patten1962
patten1962 Jul. 30 at 12:28 PM
$DGX https://newsroom.questdiagnostics.com/2025-07-29-Athena-Diagnostics-Improves-Ataxia-Movement-Disorder-Testing-with-Novel-Long-Read-Gene-Sequencing?s=09 $PACB
0 · Reply
patten1962
patten1962 Jul. 30 at 12:27 PM
$PACB Today is a great example of this Stocktwits $PACB forum. 14k followers. Maybe I wrong but I think $DGX News with PacBio is pretty positive. Very few reactions. Find it odd.
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 28 at 4:52 PM
$DGX Brilliant piece that captures DGX's situation perfectly. So if you want to update your understanding of DGX or get to know DGX better, this is essential reading. https://beyondspx.com/article/quest-diagnostics-powering-growth-through-precision-and-strategic-expansion-nyse-dgx
0 · Reply
ChillllinTheMost
ChillllinTheMost Jul. 28 at 1:21 PM
$VCYT am I the only one that seems like a $DGX $LH or $TEM could come in and buy this cash rich company?
0 · Reply
andftbl
andftbl Jul. 24 at 2:01 PM
$DGX this looks really promising
0 · Reply
JarvisFlow
JarvisFlow Jul. 23 at 7:07 PM
UBS has updated their rating for Quest Diagnostics ( $DGX ) to Neutral with a price target of 180.
0 · Reply
JarvisFlow
JarvisFlow Jul. 23 at 2:58 PM
Truist Securities has updated their rating for Quest Diagnostics ( $DGX ) to Hold with a price target of 192.
0 · Reply
JarvisFlow
JarvisFlow Jul. 23 at 2:26 PM
Deutsche Bank updates rating for Quest Diagnostics ( $DGX ) to Hold, target set at 160 → 178.
0 · Reply
Small_time_trader
Small_time_trader Jul. 22 at 3:36 PM
$DGX Jim Davis be like
0 · Reply
Latest News on DGX
Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing

Jul 29, 2025, 8:52 AM EDT - 4 days ago

Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing

PACB

Quest Diagnostics Raises Outlook, But Warns Of Tariff And Medicare Act Risks

Jul 22, 2025, 1:10 PM EDT - 11 days ago

Quest Diagnostics Raises Outlook, But Warns Of Tariff And Medicare Act Risks

Quest Diagnostics Incorporated (DGX) Q2 2025 Earnings Call Transcript

Jul 22, 2025, 12:22 PM EDT - 11 days ago

Quest Diagnostics Incorporated (DGX) Q2 2025 Earnings Call Transcript

Quest Diagnostics raises annual forecasts on strong diagnostic testing demand

Jul 22, 2025, 7:17 AM EDT - 11 days ago

Quest Diagnostics raises annual forecasts on strong diagnostic testing demand

Quest Diagnostics Reports Second Quarter 2025 Financial Results; Raises Guidance for Full Year 2025

Jul 22, 2025, 6:47 AM EDT - 11 days ago

Quest Diagnostics Reports Second Quarter 2025 Financial Results; Raises Guidance for Full Year 2025

Quest Diagnostics Introduces Testing for Oropouche Virus

Jul 15, 2025, 7:57 AM EDT - 18 days ago

Quest Diagnostics Introduces Testing for Oropouche Virus

Quest Diagnostics: Buy Into Future Patient Demand, At An Undervalued Price Today

Jul 15, 2025, 7:36 AM EDT - 18 days ago

Quest Diagnostics: Buy Into Future Patient Demand, At An Undervalued Price Today

Quest Diagnostics to Offer FDA-Cleared Fujirebio Blood Test for Alzheimer's Disease

Jul 9, 2025, 8:24 AM EDT - 24 days ago

Quest Diagnostics to Offer FDA-Cleared Fujirebio Blood Test for Alzheimer's Disease

Quest Diagnostics Releases 2024 Corporate Responsibility Report

Jun 25, 2025, 9:07 AM EDT - 5 weeks ago

Quest Diagnostics Releases 2024 Corporate Responsibility Report

Quest Diagnostics to Release Second Quarter 2025 Financial Results on July 22, 2025

Jun 23, 2025, 10:52 AM EDT - 5 weeks ago

Quest Diagnostics to Release Second Quarter 2025 Financial Results on July 22, 2025

Quest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology

Jun 10, 2025, 8:03 AM EDT - 7 weeks ago

Quest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology

More Americans Know Their Streaming Platform Passwords by Heart Than Their Cholesterol Score, New Survey Reveals

May 20, 2025, 8:52 AM EDT - 2 months ago

More Americans Know Their Streaming Platform Passwords by Heart Than Their Cholesterol Score, New Survey Reveals

Quest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference

May 16, 2025, 1:11 PM EDT - 2 months ago

Quest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference

Quest Diagnostics Declares Quarterly Cash Dividend

May 14, 2025, 6:17 PM EDT - 2 months ago

Quest Diagnostics Declares Quarterly Cash Dividend

Oncologists Report Seeing More Advanced Cancers and Say Current Tests Are Not Catching Cancer Recurrence Early Enough, New Quest Diagnostics Report Finds

May 13, 2025, 6:03 AM EDT - 2 months ago

Oncologists Report Seeing More Advanced Cancers and Say Current Tests Are Not Catching Cancer Recurrence Early Enough, New Quest Diagnostics Report Finds

Quest Diagnostics: A Leader But Waiting For Better Price

May 3, 2025, 4:26 AM EDT - 3 months ago

Quest Diagnostics: A Leader But Waiting For Better Price

These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Q1 Earnings

Apr 23, 2025, 1:17 PM EDT - 3 months ago

These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Q1 Earnings

Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence

Apr 22, 2025, 12:09 PM EDT - 3 months ago

Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence

Quest Diagnostics Incorporated (DGX) Q1 2025 Earnings Call Transcript

Apr 22, 2025, 11:39 AM EDT - 3 months ago

Quest Diagnostics Incorporated (DGX) Q1 2025 Earnings Call Transcript

Quest beats quarterly profit estimates on strong demand for diagnostic tests

Apr 22, 2025, 7:37 AM EDT - 3 months ago

Quest beats quarterly profit estimates on strong demand for diagnostic tests

Quest Diagnostics earnings beat after March rebound in demand from slump early in the quarter

Apr 22, 2025, 7:01 AM EDT - 3 months ago

Quest Diagnostics earnings beat after March rebound in demand from slump early in the quarter

Quest Diagnostics Reports First Quarter 2025 Financial Results; Reaffirms Revenue and Adjusted Diluted EPS Guidance for Full Year 2025

Apr 22, 2025, 6:43 AM EDT - 3 months ago

Quest Diagnostics Reports First Quarter 2025 Financial Results; Reaffirms Revenue and Adjusted Diluted EPS Guidance for Full Year 2025

Quest Diagnostics Launches New AD-Detect™ Blood Test to Aid in Confirming Alzheimer's Disease

Apr 9, 2025, 7:53 AM EDT - 4 months ago

Quest Diagnostics Launches New AD-Detect™ Blood Test to Aid in Confirming Alzheimer's Disease

8 Upcoming Dividend Increases During Volatile Times

Apr 4, 2025, 1:43 PM EDT - 4 months ago

8 Upcoming Dividend Increases During Volatile Times

AMT BKU GD KAI ORCL REIT RNP

Quest Diagnostics Introduces HPV Specimen Self-Collection for Cervical Cancer Screening

Apr 2, 2025, 7:06 AM EDT - 4 months ago

Quest Diagnostics Introduces HPV Specimen Self-Collection for Cervical Cancer Screening

Quest Diagnostics to Release First Quarter 2025 Financial Results on April 22, 2025

Apr 1, 2025, 4:23 PM EDT - 4 months ago

Quest Diagnostics to Release First Quarter 2025 Financial Results on April 22, 2025

Quest Diagnostics to Highlight Strategic Priorities to Drive Sustainable Growth and Deliver Long-term Shareholder Value at 2025 Investor Day

Mar 19, 2025, 7:52 AM EDT - 4 months ago

Quest Diagnostics to Highlight Strategic Priorities to Drive Sustainable Growth and Deliver Long-term Shareholder Value at 2025 Investor Day

Quest Diagnostics to Collaborate with Google Cloud to Streamline Data and Personalize Customer Experiences Using Generative AI

Mar 18, 2025, 9:00 AM EDT - 4 months ago

Quest Diagnostics to Collaborate with Google Cloud to Streamline Data and Personalize Customer Experiences Using Generative AI

Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics

Feb 24, 2025, 8:00 AM EST - 5 months ago

Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics

FMS

Quest Diagnostics to Host Investor Day on March 19, 2025

Feb 13, 2025, 4:54 PM EST - 6 months ago

Quest Diagnostics to Host Investor Day on March 19, 2025

GRAIL and Quest Diagnostics Provide GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System

Feb 12, 2025, 9:00 AM EST - 6 months ago

GRAIL and Quest Diagnostics Provide GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System

GRAL

Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year

Jan 30, 2025, 4:14 PM EST - 6 months ago

Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year

Quest Diagnostics Incorporated (DGX) Q4 2024 Earnings Call Transcript

Jan 30, 2025, 2:35 PM EST - 6 months ago

Quest Diagnostics Incorporated (DGX) Q4 2024 Earnings Call Transcript

Quest Diagnostics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Guidance for Full Year 2025; Increases Quarterly Dividend 6.7% to $0.80 Per Share

Jan 30, 2025, 6:45 AM EST - 6 months ago

Quest Diagnostics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Guidance for Full Year 2025; Increases Quarterly Dividend 6.7% to $0.80 Per Share

Quest Diagnostics Completes Acquisition of the Outreach Lab Services Business of University Hospitals

Jan 27, 2025, 8:56 AM EST - 6 months ago

Quest Diagnostics Completes Acquisition of the Outreach Lab Services Business of University Hospitals

Quest Diagnostics Names Adrienne Brott Senior Vice President and Chief Quality and Regulatory Affairs Officer

Jan 8, 2025, 8:42 AM EST - 7 months ago

Quest Diagnostics Names Adrienne Brott Senior Vice President and Chief Quality and Regulatory Affairs Officer

Quest Diagnostics to Release Fourth Quarter and Full Year 2024 Financial Results on January 30, 2025

Jan 2, 2025, 11:00 AM EST - 7 months ago

Quest Diagnostics to Release Fourth Quarter and Full Year 2024 Financial Results on January 30, 2025

Quest Diagnostics to Speak at the 7th Annual Evercore HealthCONx Conference

Dec 3, 2024, 9:50 AM EST - 8 months ago

Quest Diagnostics to Speak at the 7th Annual Evercore HealthCONx Conference

Quest Diagnostics Launches Health Coaching on questhealth.com to Help Individuals Take Control of Their Health

Dec 3, 2024, 8:23 AM EST - 8 months ago

Quest Diagnostics Launches Health Coaching on questhealth.com to Help Individuals Take Control of Their Health

15 stocks — including Palantir and Nvidia — whose sales estimates have risen the most this earnings season

Nov 25, 2024, 10:44 AM EST - 8 months ago

15 stocks — including Palantir and Nvidia — whose sales estimates have risen the most this earnings season

NVDA PLTR APH ATO BLK CNC CTRA

Augurex Life Sciences and Quest Diagnostics Collaborate to Improve Rheumatoid Arthritis Diagnosis and Management

Nov 15, 2024, 1:05 PM EST - 9 months ago

Augurex Life Sciences and Quest Diagnostics Collaborate to Improve Rheumatoid Arthritis Diagnosis and Management

Quest Diagnostics Has Massive Secular Tailwinds And A Strong Base

Oct 24, 2024, 10:10 AM EDT - 10 months ago

Quest Diagnostics Has Massive Secular Tailwinds And A Strong Base

Quest Diagnostics: Organic Growth Leads To Q3 Earnings Beat

Oct 24, 2024, 8:36 AM EDT - 10 months ago

Quest Diagnostics: Organic Growth Leads To Q3 Earnings Beat

US lab operator Quest Diagnostics to launch bird flu test at end of October

Oct 23, 2024, 8:08 AM EDT - 10 months ago

US lab operator Quest Diagnostics to launch bird flu test at end of October

Quest Diagnostics Awarded CDC Contracts for H5 Avian Influenza and Oropouche Virus Test Development

Oct 23, 2024, 7:53 AM EDT - 10 months ago

Quest Diagnostics Awarded CDC Contracts for H5 Avian Influenza and Oropouche Virus Test Development

Overlooked Stock: DGX

Oct 22, 2024, 4:57 PM EDT - 10 months ago

Overlooked Stock: DGX

Quest Diagnostics (DGX) Q3 2024 Earnings Call Transcript

Oct 22, 2024, 11:40 AM EDT - 10 months ago

Quest Diagnostics (DGX) Q3 2024 Earnings Call Transcript

Quest Diagnostics CEO Touts 'New Customer Wins' In Q3, Expects Earnings Growth In 2025

Oct 22, 2024, 11:08 AM EDT - 10 months ago

Quest Diagnostics CEO Touts 'New Customer Wins' In Q3, Expects Earnings Growth In 2025

Quest Diagnostics beats quarterly results estimates on diagnostic test demand

Oct 22, 2024, 8:05 AM EDT - 10 months ago

Quest Diagnostics beats quarterly results estimates on diagnostic test demand

Quest Diagnostics Reports Third Quarter 2024 Financial Results; Updates Guidance for Full Year 2024

Oct 22, 2024, 6:45 AM EDT - 10 months ago

Quest Diagnostics Reports Third Quarter 2024 Financial Results; Updates Guidance for Full Year 2024

andftbl
andftbl Aug. 1 at 4:28 PM
$DGX Back up?
0 · Reply
patten1962
patten1962 Jul. 30 at 12:28 PM
$DGX https://newsroom.questdiagnostics.com/2025-07-29-Athena-Diagnostics-Improves-Ataxia-Movement-Disorder-Testing-with-Novel-Long-Read-Gene-Sequencing?s=09 $PACB
0 · Reply
patten1962
patten1962 Jul. 30 at 12:27 PM
$PACB Today is a great example of this Stocktwits $PACB forum. 14k followers. Maybe I wrong but I think $DGX News with PacBio is pretty positive. Very few reactions. Find it odd.
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 28 at 4:52 PM
$DGX Brilliant piece that captures DGX's situation perfectly. So if you want to update your understanding of DGX or get to know DGX better, this is essential reading. https://beyondspx.com/article/quest-diagnostics-powering-growth-through-precision-and-strategic-expansion-nyse-dgx
0 · Reply
ChillllinTheMost
ChillllinTheMost Jul. 28 at 1:21 PM
$VCYT am I the only one that seems like a $DGX $LH or $TEM could come in and buy this cash rich company?
0 · Reply
andftbl
andftbl Jul. 24 at 2:01 PM
$DGX this looks really promising
0 · Reply
JarvisFlow
JarvisFlow Jul. 23 at 7:07 PM
UBS has updated their rating for Quest Diagnostics ( $DGX ) to Neutral with a price target of 180.
0 · Reply
JarvisFlow
JarvisFlow Jul. 23 at 2:58 PM
Truist Securities has updated their rating for Quest Diagnostics ( $DGX ) to Hold with a price target of 192.
0 · Reply
JarvisFlow
JarvisFlow Jul. 23 at 2:26 PM
Deutsche Bank updates rating for Quest Diagnostics ( $DGX ) to Hold, target set at 160 → 178.
0 · Reply
Small_time_trader
Small_time_trader Jul. 22 at 3:36 PM
$DGX Jim Davis be like
0 · Reply
Small_time_trader
Small_time_trader Jul. 22 at 1:52 PM
$DGX Printing $$
0 · Reply
ZacksResearch
ZacksResearch Jul. 22 at 1:45 PM
$DGX crushes Q2 estimates — what’s driving the growth? 🚀 ⚡ EPS beat by 1.9% and revenue surged 15.2% YoY 📈 Volumes up 16.3% with strategic execution supporting growth 🔮 Raised full-year guidance adds more appeal See the full breakdown here 👉 https://www.zacks.com/stock/news/2602868/quest-diagnostics-beats-q2-earnings-revenue-estimates-stock-rises?cid=sm-stocktwits-2-2602868-body-2966&ADID=SYND_STOCKTWITS_TWEET_2_2602868_BODY_2966
0 · Reply
ZacksResearch
ZacksResearch Jul. 22 at 11:55 AM
$DGX just crushed Q2 — is this the breakout bulls were waiting for? 15.2% revenue growth and a big EPS beat pushed the stock up 3.2% pre-market. Full breakdown here 👉 https://www.zacks.com/stock/news/2602868/quest-diagnostics-beats-q2-earnings-revenue-estimates-stock-rises?cid=sm-stocktwits-2-2602868-teaser-2961&ADID=SYND_STOCKTWITS_TWEET_2_2602868_TEASER_2961
0 · Reply
DonCorleone77
DonCorleone77 Jul. 22 at 11:00 AM
$DGX Quest Diagnostics raises FY25 adjusted EPS view to $9.63-$9.83 from $9.55-$9.80 -- Consensus $9.70.
0 · Reply
DonCorleone77
DonCorleone77 Jul. 22 at 10:58 AM
$DGX Quest Diagnostics reports Q2 adjusted EPS $2.62, consensus $2.58 -- Q2 revenue $2.76B, consensus $2.73B.
0 · Reply
CatCapital_ai
CatCapital_ai Jul. 22 at 10:49 AM
$DGX Earnings - Q2/2025 Revenue: $2.76 ✅ vs. $2.73B est. EPS: $2.62 ✅ vs. $2.57 est. Quest Diagnostics raises full-year 2025 guidance on strong Q2 growth and demand for innovative solutions.
0 · Reply
Estimize
Estimize Jul. 22 at 10:00 AM
$DGX reported - EPS and - revenue for Q2. http://www.estimize.com/intro/dgx?chart=historical&metric_name=eps&utm_content=DGX&utm_medium=act
0 · Reply
stockwatcherking
stockwatcherking Jul. 21 at 3:48 PM
$DGX I like this for calls. 8/15 $170C. ER.
0 · Reply
ZacksResearch
ZacksResearch Jul. 21 at 1:00 PM
$DGX Q2 earnings preview: will they top expectations again? 🔍 Quest Diagnostics has a strong track record, beating estimates for four consecutive quarters with an average surprise of 2.03%. For Q2 2025, EPS is projected to rise 9.4% and revenues are expected to increase 13.4% from the year-ago reported figure, driven by Advanced Diagnostics and strategic acquisitions. Full earnings setup here 👉 https://www.zacks.com/stock/news/2599107/dgx-q2-earnings-preview-will-advanced-diagnostics-lead-performance?cid=sm-stocktwits-2-2599107-body-2729&ADID=SYND_STOCKTWITS_TWEET_2_2599107_BODY_2729
0 · Reply
ZacksResearch
ZacksResearch Jul. 21 at 11:47 AM
$DGX Q2 preview — Is Advanced Diagnostics the growth driver? Q2 may see a boost from Advanced Diagnostics, plus tailwinds from new health plan deals and recent acquisitions. Full earnings setup here 👉 https://www.zacks.com/stock/news/2599107/dgx-q2-earnings-preview-will-advanced-diagnostics-lead-performance?cid=sm-stocktwits-2-2599107-teaser-2721&ADID=SYND_STOCKTWITS_TWEET_2_2599107_TEASER_2721
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Jul. 15 at 12:02 PM
$DGX Quest Diagnostics Launches Diagnostic Laboratory Test For Emerging Infectious Disease Associated With Severe Neurological Affects
0 · Reply
ZacksResearch
ZacksResearch Jul. 7 at 1:09 PM
$DGX rallying 27.3% in the past year — what's fueling the surge? 🚀 📈 Strong gains in Advanced Diagnostics, especially in brain and women's health 🤝 New partnerships with Elevance Health & Sentara Health Plans effective Jan. 1, 2025 🧬 PathAI Diagnostics acquisition boosts digital pathology capabilities Discover why DGX is a Zacks Rank #2 (Buy) pick 👉 https://www.zacks.com/commentary/2565462/quest-diagnostics-stock-climbs-273-in-a-year-whats-fueling-it?cid=sm-stocktwits-2-2565462-body-814&ADID=SYND_STOCKTWITS_TWEET_2_2565462_BODY_814
0 · Reply